Clinical Trial Update: Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Omegaven for TPN-induced cholestasis (PNALD) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis
• Parenteral Nutrition Associated Liver Disease

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: University of Nebraska | Conditions: Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis | Phase 2 | Status: COMPLETED | Results posted: 2019-10-28